se of simplified HAS-BLED score for predicting bleeding events in anticoagulated patients with atrial fibrillatio
Not Applicable
Completed
- Conditions
- AF patients receiving warfarin at Central Chest Institute of Thailand.simplified HAS-BLED,atrial fibrillation,anticoagulant,bleeding,warfarin
- Registration Number
- TCTR20200105005
- Lead Sponsor
- o
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
AF patients who were received warfarin.
Exclusion Criteria
1. Contraindication of warfarin or warfarin use less than 1 year
2. Each INR level was checked more than 6 months
3. All types of prosthetic heart valve including mitral valve repair
4. Patients with thrombocytopenia, myeloproliferative disorders (essential thrombocythemia, chronic myeloid leukemia, polycythemia vera, agnogenic myeloid metaplasia), hyperviscosity syndrome or cirrhosis
5. Pregnancy
6. Patients participating in other concealed study
7. Warfarin interruption from surgery or invasive procedure during study
8. Hospitalization during study
9. Warfarin discontinuation during study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major bleeding, nonmajor clinically relevant bleeding and/or minor bleeding At follow up visit proportion of bleeding events
- Secondary Outcome Measures
Name Time Method /A N/A N/A